Project

NGS-based Alzheimer's Risk Analysis Software

Project Summary

Through our NGS-based risk analysis software, we provide users with genetic analysis information associated with Alzheimer's disease, allowing users to personalize and optimize their health care. The result of the analysis is provided in the form of a Health Risk Report that is designed to help users easily understand their genetic variations. This report is constantly updated to take new studies and findings into account. Through a user-interactive app, we collect everyday information about our users and give health-related suggestions.

Business Model

We have two business models: Direct-to-consumer(DTC) and Business-to-business(B2B).
As our DTC service, we provide Disease Risk Report Service for people who want to effectively manage their health through genetic analysis.
As our B2B service, we provide NGS-Based Genome Analysis Software for research facilities, healthcare organizations, and hospitals that want to efficiently perform genetic analysis.

Main Achievements

We have two patent transfers regarding Protein Network and Biological Network Analysis and were chosen as K-Global 300.